Patients receiving eculizumab have an increased risk for meningococcal disease, but most reported cases are attributable to encapsulated meningococcal strains. We describe a case in which a nongroupable meningococcal strain, which rarely causes disease in healthy persons, caused fatal disease in an eculizumab recipient despite meningococcal vaccination.
CITATION STYLE
Nolfi-Donegan, D., Konar, M., Vianzon, V., MacNeil, J., Cooper, J., Lurie, P., … McNamara, L. (2018). Fatal nongroupable neisseria meningitidis disease in vaccinated patient receiving eculizumab. Emerging Infectious Diseases, 24(8), 1561–1564. https://doi.org/10.3201/eid2408.180228
Mendeley helps you to discover research relevant for your work.